About Dr. Zainul Aabideen
Dr. Zainul Aabideen is a Consultant and Head of Pediatric Hematology and Oncology at Burjeel Medical City, Abu Dhabi. A British-trained specialist, he brings over 20 years of international clinical experience in pediatric blood disorders, childhood cancers, and bone marrow transplantation across the United Kingdom, India, and the United Arab Emirates.
Dr. Aabideen trained at leading UK institutions including the Royal Marsden Hospital, University College London Hospitals, Manchester Children's Hospital, Imperial College London, and the Great North Children's Hospital. He played a pioneering role in establishing one of the first comprehensive pediatric bone marrow transplant programs in the UAE, where he has successfully performed over 50 pediatric bone marrow transplants, including matched related, haploidentical, and autologous procedures.
He is committed to evidence-based, compassionate care for children with complex hematological and oncological conditions, working within multidisciplinary teams to optimize patient outcomes.
Conditions Treated by Dr. Zainul Aabideen
Areas of Interest
- Pediatric hematology
- Pediatric oncology
- Bone marrow transplantation
- Childhood leukemia and lymphoma
- Blood disorders in children
Qualifications
Work Experience
- Consultant, Head of Pediatric Hematology and Oncology, Burjeel Medical City, Abu Dhabi
- Training and clinical experience at Royal Marsden Hospital, UK
- Training and clinical experience at University College London Hospitals, UK
- Training and clinical experience at Manchester Children's Hospital, UK
- Training and clinical experience at Imperial College London, UK
- Training and clinical experience at Great North Children's Hospital, UK
- Clinical experience in India and the United Arab Emirates
Certifications (0)
Memberships (0)
Research Papers & Publications (0)
Procedures
Frequently Asked Questions
Dr. Aabideen specializes in pediatric hematology and oncology, with particular expertise in bone marrow transplantation for children with blood disorders and cancers.